6850 logo

BiOptic TPEX:6850 Stock Report

Last Price

NT$43.00

Market Cap

NT$1.3b

7D

-3.2%

1Y

-3.2%

Updated

22 Dec, 2024

Data

Company Financials

6850 Stock Overview

A biotechnology instrumentation company, develops scientific products for research and clinical applications. More details

6850 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

BiOptic Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for BiOptic
Historical stock prices
Current Share PriceNT$43.00
52 Week HighNT$63.00
52 Week LowNT$42.00
Beta0
1 Month Change-3.04%
3 Month Change-19.17%
1 Year Change-3.21%
3 Year Change20.73%
5 Year Changen/a
Change since IPO4.99%

Recent News & Updates

Recent updates

Shareholder Returns

6850TW Medical EquipmentTW Market
7D-3.2%-2.0%-2.1%
1Y-3.2%-5.9%25.6%

Return vs Industry: 6850 exceeded the TW Medical Equipment industry which returned -5.9% over the past year.

Return vs Market: 6850 underperformed the TW Market which returned 25.6% over the past year.

Price Volatility

Is 6850's price volatile compared to industry and market?
6850 volatility
6850 Average Weekly Movement4.3%
Medical Equipment Industry Average Movement3.8%
Market Average Movement4.4%
10% most volatile stocks in TW Market7.8%
10% least volatile stocks in TW Market2.1%

Stable Share Price: 6850 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 6850's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1993n/an/awww.bioptic.com.tw

BiOptic Inc., a biotechnology instrumentation company, develops scientific products for research and clinical applications. It offers instruments, such as bio-fragment analyzers and PCR thermocyclers; consumables, including DNA, RNA, and protein cartridges, as well as quantification kits; premix and polymerase PCR reagents; and veterinary, human, and food related testing kits. BiOptic Inc.was founded in 1993 and is headquartered in New Taipei City, Taiwan.

BiOptic Inc. Fundamentals Summary

How do BiOptic's earnings and revenue compare to its market cap?
6850 fundamental statistics
Market capNT$1.29b
Earnings (TTM)NT$0
Revenue (TTM)n/a

n/a

P/E Ratio

n/a

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6850 income statement (TTM)
RevenueNT$0
Cost of RevenueNT$0
Gross ProfitNT$0
Other ExpensesNT$0
EarningsNT$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did 6850 perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

n/a

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 07:32
End of Day Share Price 2024/12/20 00:00
EarningsN/A
Annual EarningsN/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BiOptic Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution